Patibandla S A, Wagle N M, Seetharamaiah G S, Fan J L, Dallas J S, Prabhakar B S
Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, USA.
Exp Clin Endocrinol Diabetes. 1996;104 Suppl 3:28-32. doi: 10.1055/s-0029-1211677.
Since the cloning of a full length cDNA encoding the thyrotropin receptor (TSHr), several laboratories have been actively trying to develop an optimal animal model to understand the pathogenesis of TSHr mediated autoimmune diseases and have made considerable progress. To date, results from our laboratory have indicated that the nature of the antigen, and the adjuvant used for immunization, immunogenetic background of the animal and fine specificities of antibodies elicited might play an important role in determining the qualitative nature of the antibody response. Although an ideal animal model for either Graves' disease or primary myxedema is not yet available, ongoing studies in our laboratory and elsewhere hold promise for establishing animal models for various TSHr mediated autoimmune diseases in the near future.
自从编码促甲状腺激素受体(TSHr)的全长cDNA被克隆以来,多个实验室一直在积极尝试开发一种理想的动物模型,以了解TSHr介导的自身免疫性疾病的发病机制,并已取得了相当大的进展。迄今为止,我们实验室的结果表明,抗原的性质、用于免疫的佐剂、动物的免疫遗传背景以及所诱导抗体的精细特异性,可能在决定抗体反应的定性性质方面发挥重要作用。尽管尚未获得用于格雷夫斯病或原发性黏液水肿的理想动物模型,但我们实验室和其他地方正在进行的研究有望在不久的将来建立各种TSHr介导的自身免疫性疾病的动物模型。